Make an appointment with a cancer specialist today.
Call us at 800-KARMANOS (800-527-6266)
Home / Physicians & Research / Karmanos Research / Types of Research

Types of Research

The Institute’s investigators conduct all forms of research into the prevention, detection, treatment and causes of cancer.

Types of Research

Basic research
A cornerstone of the Institute's cancer investigations, tracing its roots back to the establishment of the Detroit Institute for Cancer Research in 1943. Achievements include establishing the first immortal hormone dependent breast cancer cell line, MCF-7, and establishment of premalignant cell line MCF-10; and synthesis of AZT, ddC and d4T, the first FDA-approved treatments for AIDS.

Clinical research
Conducted through more than 300 clinical trials at the Institute, including one of the country's leading Phase I programs. Studies are institutional (designed/led by our own investigators), cooperative (with such groups as the Southwest Oncology Group), and pharmaceutical/industry trials. Achievements include establishing the international, nonsurgical standard therapy for anal and esophageal cancers and the concept of the multidisciplinary team, organ preservation and adjuvant chemotherapy.

Population Research 

  • Epidemiological research - Provides a quantitative portrait of cancer and its determinants in a defined population. Core functions are measurement of cancer incidence, morbidity, survival, and mortality. This also includes assessing of genetic predisposition, environmental and behavioral risk factors, screening practices, and the quality of care: from prevention through rehabilitation or hospice.
  • Behavioral research - Investigates whether racial and ethnic attitudes and biases, and real or perceived cultural differences among minority-group patients impede effective communication and decision-making in doctor-patient interactions. 

More Information 

For more information on research at Karmanos, visit the Research Portal

© 2014 Karmanos Cancer Institute Pencil
The Barbara Ann Karmanos Cancer Center is accredited by The Joint Commission.
If members of the public have any quality-of-care or safety concerns, they may notify The Joint Commission at 630-792-5800.